National Stem Cell Clinical Research Program Filing Unit

▶ In October 2021, the project “Randomized, open, parallel-controlled clinical study on the efficacy and safety of applying human umbilical cord mesenchymal stem cells in the treatment of difficult-to-heal wounds in diabetic foot” declared by Prof. Peihua Zhang and his team from the Affiliated Hospital of Guangdong Medical University and Yuanpin Bio, passed the record and approval of the National Healthcare Commission, and is the first batch of clinical research projects approved by the National Healthcare Commission. It is the first batch of clinical research projects on stem cell treatment of diabetic foot in China.